Generic instruments for drug discontinuation in primary care: A systematic review
Sign Up to like & getrecommendations! Published in 2020 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.14287
Abstract: Aims The aim of this systematic review was to identify generic instruments for drug discontinuation in patients with polypharmacy in the primary care setting. Methods We systematically searched PubMed and EMBASE, 8 guideline databases (AWMF,… read more here.
Keywords: generic instruments; instruments drug; systematic review; drug ... See more keywords
Dosing, drug reduction, drug interruption, and drug discontinuation rates among U.S. FDA approved tyrosine kinase inhibitors.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.3112
Abstract: 3112 Background: The advent of tyrosine kinase inhibitors (TKIs) has altered the therapeutic landscape of multiple hematological and solid malignancies. FDA approved starting doses of TKIs are based on the recommended phase 2 dose (RP2D)… read more here.
Keywords: fda approved; drug; discontinuation rates; drug discontinuation ... See more keywords
Understanding Study Drug Discontinuation Through EUCLID
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2022.947645
Abstract: Introduction Disparities in the care and outcomes of peripheral artery disease (PAD) have been well-established. In part this is due to disparities in enrollment of PAD trial cohorts. However, less attention has been paid to… read more here.
Keywords: drug; study drug; drug discontinuation; understanding study ... See more keywords